Global Human Blood Plasma Fractionation Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 130
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Human Blood Plasma Fractionation market size was valued at USD 31210 million in 2023 and is forecast to a readjusted size of USD 51020 million by 2030 with a CAGR of 7.3% during review period.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation
The Blood Plasma Fractionation Product market is driven by the growing demand for plasma-derived therapies and the increasing prevalence of chronic and rare diseases. Plasma fractionation involves separating and purifying plasma components to produce therapies such as immunoglobulins, clotting factors, and albumin. The rise in awareness about the therapeutic benefits of plasma-derived products and the need for specialized treatments contribute to market growth as patients and healthcare providers seek effective solutions. Moreover, advancements in fractionation technologies, including improved product yields and safety profiles, align with better patient outcomes. However, the market also faces challenges, including ensuring a stable supply of plasma donors and addressing regulatory complexities related to plasma collection and product manufacturing. Additionally, competition from alternative therapies and addressing concerns about supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and safe plasma fractionation products, collaborate with healthcare professionals for therapeutic insights, and address the challenges to meet the increasing demand for specialized and life-saving plasma-derived therapies.
The Global Info Research report includes an overview of the development of the Human Blood Plasma Fractionation industry chain, the market status of Hospital (Immune Globulin, Coagulation Factor), Retail Pharmacy (Immune Globulin, Coagulation Factor), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Blood Plasma Fractionation.
Regionally, the report analyzes the Human Blood Plasma Fractionation markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Blood Plasma Fractionation market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Human Blood Plasma Fractionation market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Blood Plasma Fractionation industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immune Globulin, Coagulation Factor).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Blood Plasma Fractionation market.
Regional Analysis: The report involves examining the Human Blood Plasma Fractionation market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Blood Plasma Fractionation market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Human Blood Plasma Fractionation:
Company Analysis: Report covers individual Human Blood Plasma Fractionation players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Blood Plasma Fractionation This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Retail Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Human Blood Plasma Fractionation. It assesses the current state, advancements, and potential future developments in Human Blood Plasma Fractionation areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Blood Plasma Fractionation market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Human Blood Plasma Fractionation market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Immune Globulin
Coagulation Factor
Albumin
Others
Market segment by Application
Hospital
Retail Pharmacy
Others
Market segment by players, this report covers
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Blood Plasma Fractionation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Blood Plasma Fractionation, with revenue, gross margin and global market share of Human Blood Plasma Fractionation from 2019 to 2024.
Chapter 3, the Human Blood Plasma Fractionation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Human Blood Plasma Fractionation market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Blood Plasma Fractionation.
Chapter 13, to describe Human Blood Plasma Fractionation research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Human Blood Plasma Fractionation
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Human Blood Plasma Fractionation by Type
1.3.1 Overview: Global Human Blood Plasma Fractionation Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Human Blood Plasma Fractionation Consumption Value Market Share by Type in 2023
1.3.3 Immune Globulin
1.3.4 Coagulation Factor
1.3.5 Albumin
1.3.6 Others
1.4 Global Human Blood Plasma Fractionation Market by Application
1.4.1 Overview: Global Human Blood Plasma Fractionation Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Others
1.5 Global Human Blood Plasma Fractionation Market Size & Forecast
1.6 Global Human Blood Plasma Fractionation Market Size and Forecast by Region
1.6.1 Global Human Blood Plasma Fractionation Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Human Blood Plasma Fractionation Market Size by Region, (2019-2030)
1.6.3 North America Human Blood Plasma Fractionation Market Size and Prospect (2019-2030)
1.6.4 Europe Human Blood Plasma Fractionation Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Human Blood Plasma Fractionation Market Size and Prospect (2019-2030)
1.6.6 South America Human Blood Plasma Fractionation Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Human Blood Plasma Fractionation Market Size and Prospect (2019-2030)
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Human Blood Plasma Fractionation Product and Solutions
2.1.4 Takeda Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments and Future Plans
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Human Blood Plasma Fractionation Product and Solutions
2.2.4 CSL Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSL Recent Developments and Future Plans
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Human Blood Plasma Fractionation Product and Solutions
2.3.4 Grifols Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Grifols Recent Developments and Future Plans
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Human Blood Plasma Fractionation Product and Solutions
2.4.4 Octapharma Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Octapharma Recent Developments and Future Plans
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Human Blood Plasma Fractionation Product and Solutions
2.5.4 Kedrion Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Kedrion Recent Developments and Future Plans
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Human Blood Plasma Fractionation Product and Solutions
2.6.4 LFB Group Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 LFB Group Recent Developments and Future Plans
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Human Blood Plasma Fractionation Product and Solutions
2.7.4 Biotest Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biotest Recent Developments and Future Plans
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Human Blood Plasma Fractionation Product and Solutions
2.8.4 BPL Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BPL Recent Developments and Future Plans
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Human Blood Plasma Fractionation Product and Solutions
2.9.4 RAAS Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 RAAS Recent Developments and Future Plans
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Human Blood Plasma Fractionation Product and Solutions
2.10.4 CBPO Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CBPO Recent Developments and Future Plans
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Human Blood Plasma Fractionation Product and Solutions
2.11.4 Hualan Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hualan Bio Recent Developments and Future Plans
2.12 Tiantan Bio
2.12.1 Tiantan Bio Details
2.12.2 Tiantan Bio Major Business
2.12.3 Tiantan Bio Human Blood Plasma Fractionation Product and Solutions
2.12.4 Tiantan Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Tiantan Bio Recent Developments and Future Plans
2.13 Shuanglin Bio
2.13.1 Shuanglin Bio Details
2.13.2 Shuanglin Bio Major Business
2.13.3 Shuanglin Bio Human Blood Plasma Fractionation Product and Solutions
2.13.4 Shuanglin Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Shuanglin Bio Recent Developments and Future Plans
2.14 Boya Bio
2.14.1 Boya Bio Details
2.14.2 Boya Bio Major Business
2.14.3 Boya Bio Human Blood Plasma Fractionation Product and Solutions
2.14.4 Boya Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Boya Bio Recent Developments and Future Plans
2.15 Yuanda Shuyang
2.15.1 Yuanda Shuyang Details
2.15.2 Yuanda Shuyang Major Business
2.15.3 Yuanda Shuyang Human Blood Plasma Fractionation Product and Solutions
2.15.4 Yuanda Shuyang Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Yuanda Shuyang Recent Developments and Future Plans
2.16 Weiguang Bio
2.16.1 Weiguang Bio Details
2.16.2 Weiguang Bio Major Business
2.16.3 Weiguang Bio Human Blood Plasma Fractionation Product and Solutions
2.16.4 Weiguang Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Weiguang Bio Recent Developments and Future Plans
2.17 Nanyue Bio
2.17.1 Nanyue Bio Details
2.17.2 Nanyue Bio Major Business
2.17.3 Nanyue Bio Human Blood Plasma Fractionation Product and Solutions
2.17.4 Nanyue Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Nanyue Bio Recent Developments and Future Plans
2.18 KM Biologics
2.18.1 KM Biologics Details
2.18.2 KM Biologics Major Business
2.18.3 KM Biologics Human Blood Plasma Fractionation Product and Solutions
2.18.4 KM Biologics Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 KM Biologics Recent Developments and Future Plans
3.1 Global Human Blood Plasma Fractionation Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Human Blood Plasma Fractionation by Company Revenue
3.2.2 Top 3 Human Blood Plasma Fractionation Players Market Share in 2023
3.2.3 Top 6 Human Blood Plasma Fractionation Players Market Share in 2023
3.3 Human Blood Plasma Fractionation Market: Overall Company Footprint Analysis
3.3.1 Human Blood Plasma Fractionation Market: Region Footprint
3.3.2 Human Blood Plasma Fractionation Market: Company Product Type Footprint
3.3.3 Human Blood Plasma Fractionation Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Human Blood Plasma Fractionation Consumption Value and Market Share by Type (2019-2024)
4.2 Global Human Blood Plasma Fractionation Market Forecast by Type (2025-2030)
5.1 Global Human Blood Plasma Fractionation Consumption Value Market Share by Application (2019-2024)
5.2 Global Human Blood Plasma Fractionation Market Forecast by Application (2025-2030)
6.1 North America Human Blood Plasma Fractionation Consumption Value by Type (2019-2030)
6.2 North America Human Blood Plasma Fractionation Consumption Value by Application (2019-2030)
6.3 North America Human Blood Plasma Fractionation Market Size by Country
6.3.1 North America Human Blood Plasma Fractionation Consumption Value by Country (2019-2030)
6.3.2 United States Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
6.3.3 Canada Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
6.3.4 Mexico Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
7.1 Europe Human Blood Plasma Fractionation Consumption Value by Type (2019-2030)
7.2 Europe Human Blood Plasma Fractionation Consumption Value by Application (2019-2030)
7.3 Europe Human Blood Plasma Fractionation Market Size by Country
7.3.1 Europe Human Blood Plasma Fractionation Consumption Value by Country (2019-2030)
7.3.2 Germany Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
7.3.3 France Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
7.3.5 Russia Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
7.3.6 Italy Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Human Blood Plasma Fractionation Market Size by Region
8.3.1 Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Region (2019-2030)
8.3.2 China Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
8.3.3 Japan Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
8.3.4 South Korea Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
8.3.5 India Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
8.3.7 Australia Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
9.1 South America Human Blood Plasma Fractionation Consumption Value by Type (2019-2030)
9.2 South America Human Blood Plasma Fractionation Consumption Value by Application (2019-2030)
9.3 South America Human Blood Plasma Fractionation Market Size by Country
9.3.1 South America Human Blood Plasma Fractionation Consumption Value by Country (2019-2030)
9.3.2 Brazil Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
9.3.3 Argentina Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Human Blood Plasma Fractionation Market Size by Country
10.3.1 Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Country (2019-2030)
10.3.2 Turkey Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
10.3.4 UAE Human Blood Plasma Fractionation Market Size and Forecast (2019-2030)
11.1 Human Blood Plasma Fractionation Market Drivers
11.2 Human Blood Plasma Fractionation Market Restraints
11.3 Human Blood Plasma Fractionation Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Human Blood Plasma Fractionation Industry Chain
12.2 Human Blood Plasma Fractionation Upstream Analysis
12.3 Human Blood Plasma Fractionation Midstream Analysis
12.4 Human Blood Plasma Fractionation Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Human Blood Plasma Fractionation Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Human Blood Plasma Fractionation Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Human Blood Plasma Fractionation Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Human Blood Plasma Fractionation Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Takeda Company Information, Head Office, and Major Competitors
Table 6. Takeda Major Business
Table 7. Takeda Human Blood Plasma Fractionation Product and Solutions
Table 8. Takeda Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Takeda Recent Developments and Future Plans
Table 10. CSL Company Information, Head Office, and Major Competitors
Table 11. CSL Major Business
Table 12. CSL Human Blood Plasma Fractionation Product and Solutions
Table 13. CSL Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. CSL Recent Developments and Future Plans
Table 15. Grifols Company Information, Head Office, and Major Competitors
Table 16. Grifols Major Business
Table 17. Grifols Human Blood Plasma Fractionation Product and Solutions
Table 18. Grifols Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Grifols Recent Developments and Future Plans
Table 20. Octapharma Company Information, Head Office, and Major Competitors
Table 21. Octapharma Major Business
Table 22. Octapharma Human Blood Plasma Fractionation Product and Solutions
Table 23. Octapharma Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Octapharma Recent Developments and Future Plans
Table 25. Kedrion Company Information, Head Office, and Major Competitors
Table 26. Kedrion Major Business
Table 27. Kedrion Human Blood Plasma Fractionation Product and Solutions
Table 28. Kedrion Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Kedrion Recent Developments and Future Plans
Table 30. LFB Group Company Information, Head Office, and Major Competitors
Table 31. LFB Group Major Business
Table 32. LFB Group Human Blood Plasma Fractionation Product and Solutions
Table 33. LFB Group Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. LFB Group Recent Developments and Future Plans
Table 35. Biotest Company Information, Head Office, and Major Competitors
Table 36. Biotest Major Business
Table 37. Biotest Human Blood Plasma Fractionation Product and Solutions
Table 38. Biotest Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Biotest Recent Developments and Future Plans
Table 40. BPL Company Information, Head Office, and Major Competitors
Table 41. BPL Major Business
Table 42. BPL Human Blood Plasma Fractionation Product and Solutions
Table 43. BPL Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. BPL Recent Developments and Future Plans
Table 45. RAAS Company Information, Head Office, and Major Competitors
Table 46. RAAS Major Business
Table 47. RAAS Human Blood Plasma Fractionation Product and Solutions
Table 48. RAAS Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. RAAS Recent Developments and Future Plans
Table 50. CBPO Company Information, Head Office, and Major Competitors
Table 51. CBPO Major Business
Table 52. CBPO Human Blood Plasma Fractionation Product and Solutions
Table 53. CBPO Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. CBPO Recent Developments and Future Plans
Table 55. Hualan Bio Company Information, Head Office, and Major Competitors
Table 56. Hualan Bio Major Business
Table 57. Hualan Bio Human Blood Plasma Fractionation Product and Solutions
Table 58. Hualan Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Hualan Bio Recent Developments and Future Plans
Table 60. Tiantan Bio Company Information, Head Office, and Major Competitors
Table 61. Tiantan Bio Major Business
Table 62. Tiantan Bio Human Blood Plasma Fractionation Product and Solutions
Table 63. Tiantan Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Tiantan Bio Recent Developments and Future Plans
Table 65. Shuanglin Bio Company Information, Head Office, and Major Competitors
Table 66. Shuanglin Bio Major Business
Table 67. Shuanglin Bio Human Blood Plasma Fractionation Product and Solutions
Table 68. Shuanglin Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Shuanglin Bio Recent Developments and Future Plans
Table 70. Boya Bio Company Information, Head Office, and Major Competitors
Table 71. Boya Bio Major Business
Table 72. Boya Bio Human Blood Plasma Fractionation Product and Solutions
Table 73. Boya Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Boya Bio Recent Developments and Future Plans
Table 75. Yuanda Shuyang Company Information, Head Office, and Major Competitors
Table 76. Yuanda Shuyang Major Business
Table 77. Yuanda Shuyang Human Blood Plasma Fractionation Product and Solutions
Table 78. Yuanda Shuyang Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Yuanda Shuyang Recent Developments and Future Plans
Table 80. Weiguang Bio Company Information, Head Office, and Major Competitors
Table 81. Weiguang Bio Major Business
Table 82. Weiguang Bio Human Blood Plasma Fractionation Product and Solutions
Table 83. Weiguang Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Weiguang Bio Recent Developments and Future Plans
Table 85. Nanyue Bio Company Information, Head Office, and Major Competitors
Table 86. Nanyue Bio Major Business
Table 87. Nanyue Bio Human Blood Plasma Fractionation Product and Solutions
Table 88. Nanyue Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Nanyue Bio Recent Developments and Future Plans
Table 90. KM Biologics Company Information, Head Office, and Major Competitors
Table 91. KM Biologics Major Business
Table 92. KM Biologics Human Blood Plasma Fractionation Product and Solutions
Table 93. KM Biologics Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. KM Biologics Recent Developments and Future Plans
Table 95. Global Human Blood Plasma Fractionation Revenue (USD Million) by Players (2019-2024)
Table 96. Global Human Blood Plasma Fractionation Revenue Share by Players (2019-2024)
Table 97. Breakdown of Human Blood Plasma Fractionation by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Human Blood Plasma Fractionation, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 99. Head Office of Key Human Blood Plasma Fractionation Players
Table 100. Human Blood Plasma Fractionation Market: Company Product Type Footprint
Table 101. Human Blood Plasma Fractionation Market: Company Product Application Footprint
Table 102. Human Blood Plasma Fractionation New Market Entrants and Barriers to Market Entry
Table 103. Human Blood Plasma Fractionation Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Human Blood Plasma Fractionation Consumption Value (USD Million) by Type (2019-2024)
Table 105. Global Human Blood Plasma Fractionation Consumption Value Share by Type (2019-2024)
Table 106. Global Human Blood Plasma Fractionation Consumption Value Forecast by Type (2025-2030)
Table 107. Global Human Blood Plasma Fractionation Consumption Value by Application (2019-2024)
Table 108. Global Human Blood Plasma Fractionation Consumption Value Forecast by Application (2025-2030)
Table 109. North America Human Blood Plasma Fractionation Consumption Value by Type (2019-2024) & (USD Million)
Table 110. North America Human Blood Plasma Fractionation Consumption Value by Type (2025-2030) & (USD Million)
Table 111. North America Human Blood Plasma Fractionation Consumption Value by Application (2019-2024) & (USD Million)
Table 112. North America Human Blood Plasma Fractionation Consumption Value by Application (2025-2030) & (USD Million)
Table 113. North America Human Blood Plasma Fractionation Consumption Value by Country (2019-2024) & (USD Million)
Table 114. North America Human Blood Plasma Fractionation Consumption Value by Country (2025-2030) & (USD Million)
Table 115. Europe Human Blood Plasma Fractionation Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Europe Human Blood Plasma Fractionation Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Europe Human Blood Plasma Fractionation Consumption Value by Application (2019-2024) & (USD Million)
Table 118. Europe Human Blood Plasma Fractionation Consumption Value by Application (2025-2030) & (USD Million)
Table 119. Europe Human Blood Plasma Fractionation Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Human Blood Plasma Fractionation Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Type (2019-2024) & (USD Million)
Table 122. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Type (2025-2030) & (USD Million)
Table 123. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Application (2019-2024) & (USD Million)
Table 124. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Application (2025-2030) & (USD Million)
Table 125. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Region (2019-2024) & (USD Million)
Table 126. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Region (2025-2030) & (USD Million)
Table 127. South America Human Blood Plasma Fractionation Consumption Value by Type (2019-2024) & (USD Million)
Table 128. South America Human Blood Plasma Fractionation Consumption Value by Type (2025-2030) & (USD Million)
Table 129. South America Human Blood Plasma Fractionation Consumption Value by Application (2019-2024) & (USD Million)
Table 130. South America Human Blood Plasma Fractionation Consumption Value by Application (2025-2030) & (USD Million)
Table 131. South America Human Blood Plasma Fractionation Consumption Value by Country (2019-2024) & (USD Million)
Table 132. South America Human Blood Plasma Fractionation Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Type (2019-2024) & (USD Million)
Table 134. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Type (2025-2030) & (USD Million)
Table 135. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Application (2019-2024) & (USD Million)
Table 136. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Application (2025-2030) & (USD Million)
Table 137. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Country (2019-2024) & (USD Million)
Table 138. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Country (2025-2030) & (USD Million)
Table 139. Human Blood Plasma Fractionation Raw Material
Table 140. Key Suppliers of Human Blood Plasma Fractionation Raw Materials
List of Figures
Figure 1. Human Blood Plasma Fractionation Picture
Figure 2. Global Human Blood Plasma Fractionation Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Human Blood Plasma Fractionation Consumption Value Market Share by Type in 2023
Figure 4. Immune Globulin
Figure 5. Coagulation Factor
Figure 6. Albumin
Figure 7. Others
Figure 8. Global Human Blood Plasma Fractionation Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Human Blood Plasma Fractionation Consumption Value Market Share by Application in 2023
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Others Picture
Figure 13. Global Human Blood Plasma Fractionation Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Human Blood Plasma Fractionation Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Human Blood Plasma Fractionation Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Human Blood Plasma Fractionation Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Human Blood Plasma Fractionation Consumption Value Market Share by Region in 2023
Figure 18. North America Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Human Blood Plasma Fractionation Revenue Share by Players in 2023
Figure 24. Human Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Human Blood Plasma Fractionation Market Share in 2023
Figure 26. Global Top 6 Players Human Blood Plasma Fractionation Market Share in 2023
Figure 27. Global Human Blood Plasma Fractionation Consumption Value Share by Type (2019-2024)
Figure 28. Global Human Blood Plasma Fractionation Market Share Forecast by Type (2025-2030)
Figure 29. Global Human Blood Plasma Fractionation Consumption Value Share by Application (2019-2024)
Figure 30. Global Human Blood Plasma Fractionation Market Share Forecast by Application (2025-2030)
Figure 31. North America Human Blood Plasma Fractionation Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Human Blood Plasma Fractionation Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Human Blood Plasma Fractionation Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Human Blood Plasma Fractionation Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Human Blood Plasma Fractionation Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Human Blood Plasma Fractionation Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 41. France Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Human Blood Plasma Fractionation Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Human Blood Plasma Fractionation Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Human Blood Plasma Fractionation Consumption Value Market Share by Region (2019-2030)
Figure 48. China Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 51. India Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Human Blood Plasma Fractionation Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Human Blood Plasma Fractionation Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Human Blood Plasma Fractionation Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Human Blood Plasma Fractionation Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Human Blood Plasma Fractionation Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Human Blood Plasma Fractionation Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
Figure 65. Human Blood Plasma Fractionation Market Drivers
Figure 66. Human Blood Plasma Fractionation Market Restraints
Figure 67. Human Blood Plasma Fractionation Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Human Blood Plasma Fractionation in 2023
Figure 70. Manufacturing Process Analysis of Human Blood Plasma Fractionation
Figure 71. Human Blood Plasma Fractionation Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Takeda CSL Grifols Octapharma Kedrion LFB Group Biotest BPL RAAS CBPO Hualan Bio Tiantan Bio Shuanglin Bio Boya Bio Yuanda Shuyang Weiguang Bio Nanyue Bio KM Biologics
Related Reports
06 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
